ArticleCancer reports (Hoboken, N.J.)2025

Predicting Prognosis and Immunotherapy Response in Glioblastoma (GBM) With a 5-Gene CAF-Risk Signature.

Haifeng He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.